Modified-Release Hydrocortisone in Congenital Adrenal Hyperplasia

CONTEXT: Standard glucocorticoid therapy in congenital adrenal hyperplasia (CAH) regularly fails to control androgen excess, causing glucocorticoid overexposure and poor health outcomes. OBJECTIVE: We investigated whether modified-release hydrocortisone (MR-HC), which mimics physiologic cortisol sec...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Clin Endocrinol Metab
Main Authors: Merke, Deborah P, Mallappa, Ashwini, Arlt, Wiebke, Brac de la Perriere, Aude, Lindén Hirschberg, Angelica, Juul, Anders, Newell-Price, John, Perry, Colin G, Prete, Alessandro, Rees, D Aled, Reisch, Nicole, Stikkelbroeck, Nike, Touraine, Philippe, Maltby, Kerry, Treasure, F Peter, Porter, John, Ross, Richard J
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2021
Assuntos:
Clinical Research Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8063257/
https://ncbi.nlm.nih.gov/pubmed/33527139
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/clinem/dgab051
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares